Expert panelists review the current treatment landscape of biliary tract cancers and consider how the field may evolve in light of novel therapeutic strategies in the pipeline.
September 21st 2022
Opening their discussion on biliary tract cancers, a multidisciplinary panel of experts consider how specific subsets of these malignancies differ from one another.
Shared insight on the global incidence of biliary tract cancers and which risk factors most impact the likelihood of disease.
September 28th 2022
Expert perspectives on the presentation of biliary tract cancers with specific insight to the challenges inherent in reaching a timely diagnosis.
Comprehensive insight on staging biliary tract cancers followed by an overview of molecular testing and targetable clinicopathologic features.
October 5th 2022
Panelists share their perspectives on molecular testing guidelines for patients diagnosed with biliary tract cancers.
Centering discussion on early-stage biliary tract cancers, expert panelists consider the respective roles of surgery and embolization strategies in this setting.
October 12th 2022
Before closing out their review of early-stage biliary tract cancer treatment options, panelists consider the role of transplant in the setting.
Experts provide brief perspective on the use of adjuvant treatment approaches for patients with biliary tract cancers.
October 19th 2022
Shifting their focus to the advanced disease setting, panelists provide a comprehensive overview on systemic treatment modalities used in biliary tract cancers.
Focused discussion on chemotherapy treatment options commonplace in patients with advanced or metastatic biliary tract cancers.
October 26th 2022
Centering their conversation on the TOPAZ-1 clinical trial, expert panelists review the use of IO + chemotherapy in advanced biliary tract cancers.
Shared insight on efforts to identify patient subgroups that may benefit more from immunotherapy in the setting of advanced biliary tract cancers.
November 2nd 2022
Expert perspectives on the toxicity profile of immunotherapy agents and how they can be managed in patients being treated for advanced biliary tract cancers.
In the context of advanced biliary tract cancers, panelists reflect on the optimal sequencing of agents throughout multiple lines of therapy.
November 9th 2022
Expert panelists provide comprehensive insight on novel targeted agents being investigated in advanced biliary tract cancers.
Closing out their discussion on the management of biliary tract cancers, experts share excitement for future evolutions in the treatment landscape.